BC
MRNA icon

Bayforest Capital’s Moderna MRNA Stock Holding History

Bayforest Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Sell
2,064
-1,842
-47% -$95.3K 0.13% 283
2026
Q1 		$198K Sell
3,906
-18,063
-82% -$843K 0.22% 127
2025
Q4 		$648K Buy
21,969
+6,812
+45% +$185K 0.48% 8
2025
Q3 		$392K Buy
+15,157
New +$423K 0.19% 210

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Bayforest Capital's MRNA Position: Q2 2026 in Review

Bayforest Capital reduced its Moderna (MRNA) stake by 47% in Q2 2026, selling an estimated $95.3K and leaving 2,064 shares worth $145K. The position accounts for 0.13% of the portfolio, ranked #283.

Bayforest Capital first reported a position in MRNA in Q3 2025 and has held it in 4 quarters since. The position peaked at $648K in Q4 2025. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Bayforest Capital held 2,064 shares of Moderna worth $145K as of Q2 2026.
  • Bayforest Capital sold 1,842 Moderna shares in Q2 2026, an estimated $95.3K.
  • Moderna made up 0.13% of Bayforest Capital's portfolio in Q2 2026, its #283 holding.
  • Bayforest Capital first reported a position in Moderna in Q3 2025 and has held it in 4 quarters since.
  • Bayforest Capital's Moderna position peaked at $648K in Q4 2025.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.